| Product Information |
DR-XY48284_PI_01.pdf
|
| Registration Number |
DR-XY48284
|
| Generic Name |
Lamivudine + Tenofovir disoproxil Fumarate + Dolutegravir (as sodium)
|
| Brand Name |
Acriptega
|
| Dosage Strength |
300 mg/300 mg/50 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Direct Acting Antiviral
|
| Packaging |
Blue colored HDPE Plastic Bottle with blue opaque Polypropylene Cap with silica gel (as dessicant) (Box of 1 bottle x 30 tablets)
|
| Manufacturer |
Mylan Laboratories Limited
|
| Country of Origin |
India
|
| Trader |
N/A
|
| Importer |
Faberco Life Sciences Inc.
|
| Distributor |
N/A
|
| Application Type |
Monitored Release
|
| Issuance Date |
07 March 2023
|
| Expiry Date |
15 August 2027
|